Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:94-102
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skyrme-Jones, R. A. P.
Right arrow Articles by Meredith, I. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skyrme-Jones, R. A. P.
Right arrow Articles by Meredith, I. T.

Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study

R. Andrew P. Skyrme-Jones, BSc, MB, ChB*,1, Richard C. O’Brien, MBBS, PhD{dagger}, Karen L. Berry, BSc* and Ian T. Meredith, MBBS, PhD*

* Centre for Heart and Chest Research, Monash Medical Centre and Monash University, Melbourne, Australia
{dagger} Department of Medicine, Monash Medical Centre and Monash University, Melbourne, Australia



View larger version (22K):

[in a new window]
 
Figure 1 a, Plasma VEC in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin E–treated subgroup (open bar at baseline; solid bar after treatment). b, Low density lipoprotein VEC in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin E–treated subgroup (open bar at baseline; solid bar after treatment).

 


View larger version (25K):

[in a new window]
 
Figure 2 a, Flow-mediated dilation in placebo subgroup (striped bars at baseline; solid bar after treatment) and vitamin E–treated subgroup (open bar at baseline; solid bar after treatment). Flow-mediated dilation was not altered in the placebo group, but showed a significant increase after vitamin E therapy. b, Nitroglycerin-induced vasodilation. After vitamin E supplementation, there was a trend toward an improvement in the NTG response.

 


View larger version (19K):

[in a new window]
 
Figure 3 a, Relation between the change ({Delta}) in FMD and the change in LDL VEC at follow-up in the cohort. As the {Delta}LDL vitamin E increases, so does the magnitude of {Delta}FMD (r = 0.42, p < 0.05). b, Relation between {Delta}FMD and the change in lag time to oxidation of LDL at follow-up. Reduced oxidative susceptibility after vitamin E supplementation is associated with improved FMD (r = 0.64, p < 0.0001).

 


View larger version (17K):

[in a new window]
 
Figure 4 Absolute forearm blood flow (a) and absolute forearm vascular resistance (b) during graded intra-arterial infusion of ACh before (open circles) and after (solid circles) therapy with vitamin E and before (open squares) and after (solid squares) placebo. Absolute forearm blood flow and vascular resistance were augmented after vitamin E therapy, but there was no change in the response in the placebo group (ANOVA, p < 0.05).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement